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Abstract
Objective To assess whether the multitherapy antenatal
education ‘CTLB’ (Complementary Therapies for Labour
and Birth) Study programme leads to net cost savings.
Design Cost analysis of the CTLB Study, using analysis of
outcomes and hospital funding data.
Methods We take a payer perspective and use Australian
Refined Diagnosis-Related Group (AR-DRG) cost data to
estimate the potential savings per woman to the payer
(government or private insurer). We consider scenarios in
which the intervention cost is either borne by the woman
or by the payer. Savings are computed as the difference in
total cost between the control group and the study group.
Results If the cost of the intervention is not borne by the
payer, the average saving to the payer was calculated
to be $A808 per woman. If the payer covers the cost of
the programme, this figure reduces to $A659 since the
average cost of delivering the programme was $A149
per woman. All these findings are significant at the 95%
confidence level. Significantly more women in the study
group experienced a normal vaginal birth, and significantly
fewer women in the study group experienced a caesarean
section. The main cost saving resulted from the reduced
rate of caesarean section in the study group.
Conclusion The CTLB antenatal education programme
leads to significant savings to payers that come from
reduced use of hospital resources. Depending on which
perspective is considered, and who is responsible for
covering the cost of the programme, the net savings vary
from $A659 to $A808 per woman. Compared with the
average cost of birth in the control group, we conclude that
the programme could lead to a reduction in birth-related
healthcare costs of approximately 9%.
Trial registration number ACTRN12611001126909.

Introduction
There has been a rise in rates of intervention
during labour and birth in most countries,1 2
and intervention rates in Australia are well
above the Organisation for Economic Cooperation and Development averages.3 Epidural
rates in New South Wales hospitals have
shown a rise over the past decade. In 2012,
the state average for epidural block (EDB)

Strengths and limitations of this study
►► This study is the first to demonstrate the cost

savings that could accrue to payers from an
effective antenatal education programme to reduce
intervention rates in labour and birth.
►► From the perspective of health economics, the use
of Australian refined diagnosis-related group (ARDRG) codes, or similar international code, provides
a relatively simple way to conduct cost analyses for
particular interventions, enabling informed choices
about the added value of a proposed intervention.
►► The study examines the financial impact of reducing
caesarean section (CS) for first-time mothers, and
is timely given the global emphasis on reducing
CS rates and the budgetary constraints faced by
maternity providers in many settings.
►► Limitations of this study include that the analysis is
likely to be an underestimate of the actual amount
of medical resources saved, as the current AR-DRG
system does not capture the additional costs of
procedures such as the provision of analgaesia and
anaesthesia, which were significantly less prevalent
in the study group.
►► AR-DRG are limited, especially in the area of
obstetrics, where we were unable to use the codes
to quantify the cost savings related to the reduced
rate of epidural block (primary outcome measure of
the randomised controlled trial), and other common
labour interventions, as they are all collapsed under
the ‘normal vaginal birth’ code. The one-off costs
of setting up were also not able to be included, and
should be considered prior to implementation.

use was 46.5%, with broad variation within the
state, ranging from 15% to 82.7% depending
on region and hospital.4 5 The high use of
EDB for pain relief in labour has been identified as a contributing factor in rising rates
of augmentation, assisted vaginal births and
caesarean section (CS).6–10
Childbirth education has also seen a shift
away from birth preparation11 12 to a curriculum broadly centred on overall parent
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education.13 Findings from a systematic review on childbirth education indicated that antenatal education for
childbirth or parenthood has a role in increasing feelings
of self-confidence and agency, but they demonstrated
little impact on reducing interventions and associated
morbidity in labour.14 15 Additionally, the Cochrane
Systematic Reviews of individual complementary therapies have shown little impact on the use of epidural analgaesia and birth outcomes.16–19 This is with the exception
of acupuncture which showed a reduction in overall
pharmacological pain relief, and specifically epidural
analgesia in two clinical trials,20 21 when compared with
placebo control or standard care, and a reduction in
instrumental vaginal birth when compared with standard
care.19
Australian data suggest that complementary medicine (CM) use is popular,22–24 and that 74.4% of women
used some form of CM during pregnancy and 66.7% of
these women also used non-pharmacological pain relief
in labour.25 Building on this information, the Complementary Therapies for Labour and Birth (CTLB) Study
was set up as an of an antenatal education programme of
complementary therapies plus usual care, compared with
usual care alone, for nulliparous women.26 We included
several different therapies that had some evidence of
effect for pain relief,17 27–30 giving women, and their birth
partners, the opportunity to choose from a variety of
options during the course of their labour, as every woman
and labour is different and the requirements throughout
labour are changeable. Some therapies fitted more naturally with different women’s attitudes, beliefs and physical characteristics. The study demonstrated a significant
decrease in the use of epidural analgaesia and in other
interventions during labour and birth for women in the
study group compared with the control group. The study
showed no particular statistical association of any one
therapy with the outcome of epidural analgaesia, and
women used an average of three to four different therapies throughout their labour. It was hypothesised that the
effect was produced from an overall synergistic effect of
the programme and the provision of choice and education for women and partners.
Previous research has shown the increased costs
associated with different modes of birth,31–33 and the
cascade of interventions associated with epidural use
has been costed according to birth outcomes.34 Additionally, research using cost-effectiveness analysis has
demonstrated equivalence of costs using international cost data for grouped outcomes associated with
expectant management compared with immediate birth
for the PPROMT Trial (Preterm Premature Rupture of
Membranes close to Term).35 However, there is as yet
no standard method of assessing the cost-effectiveness
of a multitherapy programme that potentially affects
multiple linked outcomes, as was the case in the CTLB
study.
2

Methods
The CTLB Study was a multicentre randomised controlled
trial (RCT), where nulliparous women with a singleton,
low-risk pregnancy between 24+0 and 34+6 weeks’ gestation were randomly allocated to receive a 2-day antenatal
education course plus usual care, or to usual care alone.
Those allocated to receive the CTLB antenatal education
course participated in a weekend workshop that focused
on complementary therapy techniques for non-pharmacological pain relief methods for labour and birth and
education about the physiology of normal labour and
birth. Women were recruited to the trial via three sites
at two hospitals in Sydney, Australia. The methods of the
CTLB study, and the clinical and qualitative outcomes
have been described in detail previously in Levett et al.26 36
The primary outcome for the original RCT was epidural
use for pain relief. Secondary outcomes included mode
of birth, onset of labour, interventions during labour,
pharmacological analgaesia use, any complications
during labour or birth for the mother, any complications
for the baby and admission to any special care units. In
this paper, we focus on the analysis of costs, comparing
costs in the study group with costs in the control group.
For the cost analysis, in each arm of the study the
participants were assigned a single outcome for labour
and birth, which was based on the highest level of intervention received during labour and birth. Each outcome
was categorised according to the Australian Refined
Diagnosis-Related Group (AR-DRG) codes, which groups
together hospital admissions of the same clinical type
that use similar amounts of hospital resources. This
categorisation is a crucial step since hospitals are reimbursed the same amount for all admissions in the same
AR-DRG group, although some small adjustments are
usually made. Therefore, we costed each admission in
the study by the average cost of admission in the corresponding AR-DRG. Each year, the Australian government
publishes data regarding the average cost of admission for
each AR-DRG. For this paper, we used the latest release,
‘Round 18’, for the financial year 2013–2014.37
This costing method was chosen because it correctly
represents the medical cost incurred by the payer and
because it could be used to make cost predictions to
other comparable international systems with DRG-based
payments. The rationale for this perspective is presented
in the next section, together with a more detailed description of how the cost analysis was performed.
There are six relevant, mutually exclusive, AR-DRG
categories that can be used to label the mother in-hospital stay for this study: O60C, O60B, O60A, O01C,
O01B and O01A (table 1). However, none of the admissions in the study belonged to O01A or O60A, which
denote births with catastrophic complications and major
morbidity, which are extremely rare, such as embolism
and severe complications of pre-eclampsia , such as
Haemolysis, Elevated Liver enzymes, and Low Platelet
count (HELLP) syndrome. While the algorithm to classify each birth in one of those codes is complex, generally
Levett KM, et al. BMJ Open 2018;8:e017333. doi:10.1136/bmjopen-2017-017333
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Table 1 Australian Refined Diagnosis-Related Group (AR-DRG) codes and their meaning
AR-DRG code

Categorisation and intervention included in AR-DRG code (each category is
mutually exclusive)

Average cost of
admission ($A)

O60B

This category includes women who had no intervention, or received any of the
following: received an induction of labour, augmentation of labour, epidural analgaesia,
narcotic pain relief and/or minor perineal trauma
4832
This category includes women who had any of the following: instrumental vaginal
birth with vacuum or forceps, had a postpartum haemorrhage, third-degree or fourthdegree perineal tear, episiotomy or other ‘non-severe’ complications
6423

O01C

This category includes women who had an uncomplicated caesarean section, with or
without labour

O60C

O01B
P68D

This category includes women who had a caesarean section with non-severe
complication, possibly associated with a blood loss greater than 750 mL
Admission of neonate with minimal complications requiring observation for less than
4 hours

9811
11 645
2846

Births are categorised according to the highest level of intervention. For example, a woman who had labour-induced (listed in O60C) but also
had a postpartum haemorrhage (listed in O60B) would have the birth categorised as O60B.

speaking the codes O60C (O01C) and O60B (O01B)
refer to vaginal (or caesarean) births without complications and with non-catastrophic complications, respectively. In cases of neonatal complications, where the
neonate may need additional care, such as an admission
to special care nursery or the neonatal intensive care unit,
there are also AR-DRGs associated. For the births in this
study, we only had information stating yes or no to any
admission. Therefore, we applied only one AR-DRG of
this category corresponding to the least complicated category of babies requiring observation for less than 4 hours,
P68D. A more detailed clinical description of meaning
of the four AR-DRGs for the mother’s stay and the P68D
AR-DRG is presented in table 1 together with the corresponding average cost of admission. To summarise, each
birth is associated with only one of the AR-DRGs from the
‘O’ category corresponding to the highest level of intervention experienced during the birth, and may or may
not be associated with the P68D AR-DRG.
Cost analysis
The key element of any cost analysis is the specification of
which costs are included and for whom they accrue. The
combination of these characteristics of the study defines
the economic perspective taken. For example, if we were
to take the payer perspective, we would only include
the actual cost to payer (in this case the DRG payment)
and possibly the cost of the programme, depending on
whether we think this cost will be covered by the payer
or the individuals. If we took the provider perspective,
we would include as cost the actual amount of resources
used by the hospital, minus the payment received by the
payer, and again possibly the cost of the programme.
The broadest perspective is the societal one in which it
is irrelevant whom the costs accrue to and all healthcare
costs are included, as well as non-healthcare costs (such as
transportation or lost productivity) and intangible costs
(such as pain and suffering). These three perspectives
have been summarised in table 2.
Levett KM, et al. BMJ Open 2018;8:e017333. doi:10.1136/bmjopen-2017-017333

Since this study intends to inform health policy, it would
be ideal to adopt a societal perspective. The largest cost
component in this perspective is the medical resource use.
We were not able to directly measure the resource use for
each birth since that would have required a much closer
collaboration with the hospital financial department
and a degree of complexity that was simply not possible
within the limited funding and scope of this pilot project.
This limitation could be partially overcome by noticing
that we only need to compare the average resource use
in the intervention and control arms, and therefore the
DRG costing method we have adopted, which is based on
average costs, should provide a sufficiently close approximation of the actual resource use.
The next key cost to include in the societal perspective
is the programme cost, and this poses no problem since
it has been measured, as discussed in the section below.

Table 2 Stylised view of different economic perspectives
(on the columns) and some of the costs they include
Societal Payer
Medical cost (DRG)

X

Medical cost (actual resource
use)

X

Programme cost

X

Transfers/payments
Transportation and other direct
non-healthcare costs

Provider

X
X (?)

X (?)
X

X

Lost productivity and other
indirect non-healthcare costs

X

Intangible costs

X

We outlined in green the costs measured in this study. The cost
highlighted in blue is not measured, but it can be approximated
by the DRG Medical Cost. The question marks mean that
the cost may or may not be included, depending on how the
programme is implemented.
DRG, Diagnosis-Related Group.
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However, as shown in table 2, in order to take a societal
perspective, we would have also to include a number of
costs that we have not been able to measure. For example,
we would need to know how much the participants (and
a birth partner, if they attended) spent in transportation, whether participation in the programme took time
away from productive or leisure time, and whether additional costs were incurred in order to participate to the
programme (eg, baby sitter, substitute caretaker). Given
the ‘pilot’ nature of this study, the collection of these
variables was simply out of scope. Therefore, we can only
provide an approximated version of the societal perspective that only includes an approximation of the hospital
resource use and the cost of the intervention, while it
misses some of the costs incurred while participating in
the programme.
However, if we adopt the payer perspective, we then
have good estimates of the costs involved. In fact, the
DRG-based approach correctly captures the payments of
payers to hospitals, and we can consider two scenarios:
one in which the cost of the programme is shouldered by
the participants, and therefore not included in the analysis, and one in which it is included because it accrues to
the payer. Therefore, the following analysis is set in the
payer perspective. The savings in the payer perspective
are most likely to provide an upper bound for those in
the societal perspective since their calculation does not
include additional costs associated with the intervention, such as transportation or lost productivity. In the
following sections, we describe in details the calculations
of the medical and intervention components of the costs.
Medical cost
We make the key assumption that the cost of an admission to the payer is well represented by the published
average AR-DRG cost (see table 1). There may be corrections applied to the published figures that account for
special circumstances, such as very long stays, but they
tend to be rare and unlikely to play an important role in
this analysis. All the births in the study can be assigned
one of eight possible combinations of AR-DRGs (four ‘O’
AR-DRGs and possibly the P68D AR-DRG), and for the
purposes of this paper, we refer to each of the combinations as an AR-DRG class. The medical cost of an admission in an AR-DRG class is simply the sum of the average
cost of the ‘O’ AR-DRG and the average cost of the P68D
AR-DRG, if present, as shown in table 3. The medical cost
per birth, in each arm, is the total medical cost divided by
the total number of women in that arm. The total medical
cost is equal to the sum of the medical costs over all the
AR-DRG classes, which are computed by multiplying the

number of women in each class by the average cost of
birth for that class. The medical cost per woman is then
obtained dividing total cost by number of women in the
corresponding arm. In formulas:
Ctreat
medical

=

∑
α

ntreat
α Cα
Ntreat

Ccontrol
medical

=

∑
α

ncontrol
Cα
α
Ncontrol



In this formula, α runs over the eight AR-DRG classes,
ntreat
is the number of women in the treatment arm in
α
each AR-DRG class α, Cα is the average cost of admission
in AR-DRG α (shown in table 3) and Ntreat is the total
number of women in the treatment arm. Similar definitions hold for the control arm.
Programme cost
The programme is delivered by an educator to groups of
six to eight participants, with each bringing at least one
person to be a birth partner (referred to as the ‘couple’),
and it takes place over the course of 2 days of 7.5 hours
each. Using an average number of participants equal
to seven couples and a labour cost of $A35 per hour
for the educator, the labour cost per couple is equal to
$A35×7.5×2/7 = $A75. If one uses a more experienced
educator, at an hourly rate of $A70 rather than $A35, the
labour cost would rise to $A150. For the purposes of this
paper, we simply take the average of these two numbers,
$A112, and use $A75 and $A150 as lower and upper
bounds in the sensitivity analysis. If the programme were
administered to more (less) people, these costs would be
lower (higher). However, the programme was designed to
work for this group size, and it does not necessarily scale
to a larger and smaller group. Therefore, we have not
performed sensitivity analysis on the number of women
attending a session.
The intervention also includes a small component
of capital cost. In fact, each couple also receives a DVD
($A12), a booklet ($A2) and is provided with light refreshments ($A15 over 2 days). We acknowledge that one may
want to offer a more generous refreshment, valued at
double that amount. Therefore, we estimate the refreshment cost by taking the rounded average between the two
numbers, that is, $A23, with a lower bound of $A15 and
an upper bound of $A30 for the purpose of the sensitivity
analysis. This leads us to estimate the capital cost at $A12
+ $A2 + $A23 = $A37, with lower and upper bounds of
$A29 and $A44, respectively.
We make the assumption that the programme is delivered in the hospital, and that the hospital always has
spare capacity of one room for six to eight couples and
an educator, and therefore do not include the cost of

Table 3 Eight possible Australian Refined Diagnosis-Related Group (AR-DRG) classes for this study and the corresponding
average cost
AR-DRG class O60C

O60B

O01C

O01B

O60C+P68D

O60B+P68D

O01C+P68D

O01B+P68D

Cost ($A)

6423

9811

11 645

7678

9269

12 657

14 491

4

4832
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Table 4 Summary of programme costs
Minimum Maximum Estimate
Educator cost (per hour)

35

70

No of hours (over 2 days)

15

No of couples

7

Educator cost per couple

75

150

 DVD

112.5
12

 Booklet

2

 Light refreshment (over 2 days)
Capital cost per couple
Total programme cost

15

30

29

44

36.5

104

194

149

Costs included in the sensitivity analysis have ‘Minimum’ and
‘Maximum’ entries. Costs for which we assumed the uncertainty is
negligible have only the ‘Estimate’ entry. All entries in $A.

securing the space. This is an important assumption that
takes advantage of the fact that the RCT was performed
in a setting where the cost of space was ‘sunk’ (unless
we want to include costs such as lighting/electricity that
would be minimal). However, cost of space would be
substantial if the programme were to be administered in
a private setting, where a room had to be rented, or if the
programme were scaled at a level that the hospital stops
having spare capacity.
Therefore, the cost of the intervention in the setting of
the current study was approximately $A112+$A37=$A149
per woman, with a lower bound of $A104 and upper
bound of $A194. A summary of the programme costs is
shown in table 4.
Who bears this cost and whether it should be included
in the analysis depends on how one envisions this
programme implemented and paid for. A possible
scenario is one in which the cost of the programme is
borne by the women participating, who would be paying
for it out-of-pocket. Alternatively, depending on insurance arrangements, the payer might also be bearing the
cost. In order to help readers find the scenarios they are
most interested in, we will report the results as follows:
►► We will report results in which the programme cost is
met by the women;
►► We will report the results in which there is no
programme cost.
Net savings
The net savings to payers per woman delivered by the
intervention are simply the difference between the
medical cost in the control arm and the sum of medical
plus programme cost in the treatment arm.
S=

Ccontrol
medical

− Ctreat
medical

− Cinter 

Our hypothesis for this study is that S is positive and
statistically different from 0. We also consider the savings
that would accrue to payers if the cost of the programme
were borne by the woman. In this case, we do not include
the cost of the intervention in the formula above and
limit the analysis to the medical savings.
Levett KM, et al. BMJ Open 2018;8:e017333. doi:10.1136/bmjopen-2017-017333

Statistical analysis
The statistical analysis was performed in R (V.3.3.2) and
focused on the net savings variable S. We account for
two sources of variation in the measurement of S: the
stochastic nature of birth outcomes, which drives variatreat
tion in the hospital cost term Ccontrol
medical − Cmedical , and
the uncertainty in the cost of the intervention.
In order to model variation in medical costs, we used
the plain bootstrap method38 (R package ‘boot’) applied
to the difference in medical costs between the study and
control group, drawing a number of bootstrap samples
equal to 500 000. Performing ‘smooth’ bootstrap, that is,
adding a small amount of random noise to the data, did
not lead to significant changes in the results. In order to
model uncertainty in programme cost, we drew 500 000
samples from the uniform distribution for the labour
and capital components of the programme costs, using
the lower and upper bounds described above. As a result,
we obtained 500 000 possible realisations of net savings
that reflect both uncertainty in birth outcomes and in
programme costs. The distribution of these 500 000
figures is used in the next section to estimate the average
net savings and the related CI. As a sensitivity test, we
also performed a more traditional analysis using t-tests
and reached the same conclusions of the bootstrap simulation method. The advantage of the bootstrap is that it
allows visualisation of the distribution of the results and
provides additional insights, such as the probability of
experiencing any positive saving.

Results
There are eight possible outcomes for the births in
the study, corresponding to the four AR-DRGs for the
mother, which may or may not be associated with a
neonatal AR-DRG. Before showing the results for all
eight outcomes, we show in table 5 an aggregate view
that makes it clear why the study group had smaller costs
than the control group. We divide all births according to
whether a CS was performed or not. This corresponds to

Table 5 Summary of medical costs for intervention
and control group by the type of birth: with and without
caesarean section (CS)
Birth
type
Intervention No CS
Control

Cost per
birth
N
$A6174

72

CS

$A10 333 16

No CS

$A6336

CS

$A10 647 27

Net medical savings per woman

56

(%)

Overall cost per
birth
(95% CI)

81.8 $A6930 ($A6541 to
18.2 $A7340)
67.5 $A7739 ($A7243 to
32.5 $A8255)
$A808
($A163 to $A1455)

The cost per birth is simply the average cost per birth,
estimated over all the births in the corresponding category.
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Figure 1 Bootstrapped distribution of the mean of net savings per birth, with (left) and without (right) programme costs. The
blue and red lines denote the 90% and 95% CI, respectively.

using the first three letters/digits of the AR-DRG for the
mother’s admission: O60 (no CS) or O01 (CS).
The key difference between the study and the control
group is that the study group had a much lower rate of
CS (18.2%) than in the control group (32.5%) (table 5).
Since CS births in this study cost approximately $A4200
more than births without CS, it follows that the average
cost of birth in the study group was $A808 less than in
the control group, with a 95% CI of $A163 to $A1457.
Therefore, if the cost of the intervention is borne by the
woman, the payer saves an expected amount equal to
$A808 per woman.
If the payer covers the programme cost of $A149 per
woman, then the savings to the payer reduce to $A659 per
woman, with a CI of $A12 to $A1311.
Figure 1 shows the simulated distributions of the
savings and costs per birth, with the red vertical lines
showing the CI at 95% and the blue lines showing the
CI at 90%. The left side shows the net savings including
the programme cost, while the right side only shows the
medical savings.
We have reported the entire distributions of savings to
payers because they provide information that goes beyond
the usual mean and CI and provide a better picture of
the financial risk borne by the payers. In the following
section, we consider the case in which payers cover the
programme cost, and therefore we refer to the distribution shown in the left panel of figure 1. We consider four
simple questions and provide the corresponding answers:
Q1:What is the probability that a payer experiences positive
savings?
A1: It is the area of the distribution to the right of 0,
which is equal to 97.7%.
6

Q2:Conditional on the payer experiencing positive savings,
what is the expected value of those savings?
A2: It is $A677, computed as the expected value of the
distribution truncated to the right of 0.
Q3:What is the probability that a payer experiences a loss
(negative savings)?
A3: It is the area of the distribution to the left of 0,
which is equal to 2.3%.
Q4: Conditional on the payer experiencing a loss, what is the
expected value of the loss?
A4: It is $A122, computed as the expected value of the
distribution truncated to the left of 0.
We can summarise these findings by saying that payers
have a high probability (97.7%) of experiencing positive savings (averaging at $A677) and a small probability
(2.3%) of experiencing a loss (averaging at $A122). We
will come back to these figures in the context of sensitivity
analysis.
The full distribution of outcomes and costs across all
the eight possible outcomes is shown in table 6. A graphical representation is provided in figure 2, which shows
the proportion of births, for study and control group, in
the eight cost categories.
In figure 2, the cost categories are sorted in increasing
order from left to right. The figure shows that the effect
of the intervention was to shift some births from the more
expensive categories to the less costly ones since there is a
predominance of births in the intervention group (in blue)
on the left side of the figure (the less costly outcomes).
Sensitivity analysis
This programme was implemented in a specific setting
in a particular region of Australia. Other settings and
Levett KM, et al. BMJ Open 2018;8:e017333. doi:10.1136/bmjopen-2017-017333
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14 491

3 (3.4)

1 (1.1)

$A11 645×3 = $A34 935

$A12 657×1 = $A12 657

$A7739

83

1 (1.2)

2 (2.4)

5 (6)

AR-DRG, Australian Refined Diagnosis-Related Group; CS, caesarean section; NICU, neonatal intensive care unit; NVB, normal vaginal birth.

Medical cost saved by intervention
$A808
Net savings (medical cost saved minus
cost of intervention)
$A659

$A609 854

O01B_P68D

CS+complications not severe/
catastrophic+NICU

11 645

12 657

5 (6)

$A9811×12 = $A117 732 19 (22.9)

 $A6930

O01B

CS+complications not severe/
catastrophic

12 (13.6)

$A9269×4 = $A37 076

 88

O01C_P68D

CS uncomplicated+NICU

9811

4 (4.5)

12 (14.5)
0 (0)

N (%)

$A642 301

$A14 491×1 = $A14 491

$A11 645×2 = $A23 290

$A12 657×5 = $A63 285

$A9811×19 = $A186 409

$A9269×5 = $A46 345

$A6423×39 = $A250 497

$A4832×12 = $A57 984
$A7678×0 = $A0

Total medical cost

Control group

$A6423×46 = $A295 458 39 (47)

Total

O01C

CS uncomplicated

9269

46 (52.3)

$A4832×20 = $A96 640
$A7678×2 = $A15 356

Medical cost per woman

O60B_P68D

NVB+complications not severe/
catastrophic+NICU

6423

20 (22.7)
2 (2.3)

Total medical cost

$A14 491×0 = $A0

O60B

NVB+complications not severe/
catastrophic

4832
7678

AR-DRG mean medical Study group
cost per birth
N (%)

0 (0)

O60C
O60C_P68D

AR-DRG Code

Detailed summary of costs and outcomes across study and control groups

NVB uncomplicated
NVB uncomplicated+NICU

Table 6
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Figure 2 Proportion of births in each of the eight Australian Refined Diagnosis-Related Group (DRG) cost categories, for the
control and the intervention group, sorted from lower to higher costs.

locations may imply different programme costs than the
ones reported here. If additional programme costs are
incurred, payers may have less of an incentive to adopt
the programme, and therefore it seems important to
explore the implications of higher-than-anticipated
programme costs. An increase in programme costs of
ΔC dollars per woman reduces the expected savings
per woman by ΔC and alters the distribution of savings,
decreasing the probability of any positive savings and
increasing the probability of experiencing a loss. In
the previous section, we reported information about
the financial risk faced by payers by answering four
questions. Here, we study how the answers to questions 1 to 4 are affected by an increase in programme
costs. The results are shown in table 7 below.
The first line of the table simply reports the baseline case of the previous section. The following lines
show scenarios of increasing programme costs. The
additional costs were chosen in such a way that the
probability of experiencing positive savings decreases
8

smoothly from 97.7% to 90%. The table shows that
if actual programme costs are $A115 more than the
anticipated $A149 (a 77% increase), there is still a very
high probability (95%) of experiencing large positive
savings ($A580). Even if additional programme costs
were as high as $A185 (a 124% increase), the probability of observing positive savings is still 92.5%, and
the savings are still over $A500.
Interestingly, as the programme costs grow from 0 to
$A235 and the probability of experiencing loss grow
from 2.3% to 10%, the expected loss, if realised, would
only grow from $A122 to $A155. Stated differently, the
expected loss, if experienced, is quite insensitive to
increases in programme costs since for every additional
dollar in programme cost, the potential loss only grows
by 14 cents.
This analysis sheds some insights on how the results
would look from a societal perspective. We have shown
in an earlier section that, to the extent that DRG
payments adequately capture the use of healthcare
Levett KM, et al. BMJ Open 2018;8:e017333. doi:10.1136/bmjopen-2017-017333
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Table 7 Effect of additional programme costs (leftmost column) on the distribution of savings per woman
Additional
programme cost
($A)

Expected savings,
conditional on
Probability of positive positive savings
savings (%)
($A)

Probability of loss
(%)

Expected loss,
conditional on loss Expected net
($A)
savings ($A)

 0
 115

97.7
95

677
580

2.3
5

122
136

659
544

 185
 235

92.5
90

525
488

7.5
10

147
155

474
424

The figures in columns 2 to 5 are the answers to questions Q1, Q2, Q3 and Q4 of the previous section. The last column shows the expected
value of net savings.

resources, the societal perspective differs from the
payer perspective because it should include additional societal costs. Table 7 above was developed to
test additional programme costs, but it is also valid in
the scenario in which programme costs are fixed at
their baseline values and additional societal costs are
included. Therefore, the table shows that if the sum
of additional direct, indirect and intangible costs were
somewhere between $A100 and $A200, there is still a
high probability that society as a whole would benefit
a non-negligible amount from the adoption of this
programme.
Discussion
This is the first study to demonstrate the cost savings that
could accrue to payers from an effective antenatal education intervention using multiple therapies to reduce the
use of routine clinical and pharmacological interventions in labour. The mean medical savings per episode
of $A808, calculated to be more than $A97 million for
the 120 000 nulliparous births in Australia annually, are
substantial and are likely to be an underestimate of the
actual amount of medical resources saved. In fact, the
current AR-DRG system does not capture the additional
costs of procedures such as the provision of analgaesia
and anaesthesia, which were less prevalent in the study
group. Most of the medical savings in the model come
from the reduction in the rate of uncomplicated CS in
the women allocated to the antenatal programme. This
was almost half the rate for those in the control group
(14.7% vs 28.9%). Given the global emphasis on reducing
CS rates39 40 and the budgetary constraints faced by maternity providers in many settings, the potential benefits of
this intervention may be significant from both a clinical
and an economic perspective.
Implementation costs for the CTLB intervention
are minimal as antenatal education classes are already
offered to women (and their partners) as part of standard care in Australian hospitals that women pay for
separately (usually between $A100 and $A300 depending
on hospital and region). We have estimated costs of
running the 2-day course to be $A149 per woman, based
on an average midwife rate of $A52 per hour and a small
Levett KM, et al. BMJ Open 2018;8:e017333. doi:10.1136/bmjopen-2017-017333

capital cost that includes DVDs and light refreshments
(the actual midwife rate will be dependent on the level
and experience of the midwife delivering the class). This
compares very favourably when set against the medical
savings of $A808 per episode identified in this study.
From a health economics’ perspective, the use of
AR-DRG codes provides a relatively simple way to
conduct cost analyses for particular interventions. This
would enable commissioners and healthcare managers
to make informed choices about the added value of a
proposed intervention. Although the AR-DRG coding
system is unique to Australia, DRG payment systems
are widespread around the world and the model of
assigning codes to represent specific, defined care
packages is widely used. For example, The Healthcare Resource Group system employed in England
and Wales incorporates similar codes to those used
in Australia (UK Government, 2016). This has been
demonstrated in a cost-effectiveness analysis of the
Self-hypnosis for intrapartum pain (SHIP) Trial, an
antenatal education programme of 'self-hypnosis for
intrapartum pain' management in nulliparous women,
conducted in the UK.41 The analysis was conducted
from the perspective of the National Health Service
(NHS) and Personal Social Services (PSSRU), where
resource use and unit costs were obtained from the
NHS and PSSRU databases. These costs were applied
as an average cost per woman derived from overall unit
costs. Where national coding systems are analogous, it
may be feasible to compare intercountry, cost data for
a given intervention, such as in the cost analysis of the
PPROMT Trial.35
AR-DRG have the limitation of being a blunt instrument, especially in the area of obstetrics, and while they
may reflect accurately the payer costs, they may not be
as easily used to understand resource usage. In our case,
for example, we were unable to use AR-DRG to quantify
the cost savings related to the reduced rate of EDB. In
fact, labour induction, labour augmentation, epidural
analgaesia, episiotomy and minor perineal trauma are all
included under code 060C (NVB uncomplicated), independently of whether the associated resources were used
or not.
9
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Our analysis did not take into account the costs of
setting up the programme, including training and
insuring the staff who deliver it, or venue hire and staff
transport. However, some of these costs are one-off, and
therefore would become insignificant in a wider roll-out,
while others really depend on how the programme is
implemented and would require a careful analysis prior
to implementation.

permits others to distribute, remix, adapt, build upon this work non-commercially,
and license their derivative works on different terms, provided the original work is
properly cited and the use is non-commercial. See: http://creativecommons.org/
licenses/by-nc/4.0/

Conclusion
We have previously shown26 that the antenatal CTLB
programme significantly reduces epidural use and CS in
women assigned to the study group, as well as reducing a
range of other clinical interventions that have important
adverse consequences if overused in healthy women and
babies. In this paper, we have shown that in addition to
medical benefits, the CTLB programme is also associated
with significant cost saving, largely related to a reduction in CS rates in the intervention group. This will be of
interest to healthcare commissioners and providers.
The net savings to payers brought by the antenatal
programme, not including programme costs, were estimated at $A808 per woman. This figure drops to $A659
when programme costs are included. Despite the relatively small size of the sample, the evidence is strong:
computing the area to the right of the number zero in
the simulated distributions of figure 1, we estimated that
the probability of observing any positive savings, even if
programme costs were included, is 97.7%.
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